日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DNA-PKcs orchestrates CTLA-4 depletion-induced senescence in cancer cells

DNA-PKcs 调控 CTLA-4 耗竭诱导的癌细胞衰老

Lee, Je-Jung; Rhee, Woo Joong; Kim, So Young; Lee, Jisun; Jung, Su Ful; Oh, Jooyeon; Park, In Ho; Shin, Jeon-Soo

Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party KMMWP-174 study

一项韩国多发性骨髓瘤工作组KMMWP-174研究:硼替佐米维持治疗对不适合移植的新诊断多发性骨髓瘤患者的疗效、安全性和健康相关生活质量的影响

Lee, Jung Yeon; Jung, Seungpil; Choi, Suein; Park, Sung-Soo; Kim, Jin Seok; Lee, Je-Jung; Park, Seong Kyu; Kim, Hyo Jung; Lee, Gyeong-Won; Park, Young Hoon; Eom, Hyeon-Seok; Kim, Jeong-A; Kim, Min Kyoung; Kim, Yundeok; Shin, Ho-Jin; Lee, Ho Sup; Kwon, Jihyun; Min, Chang-Ki

Second Salvage Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Multiple Myeloma in the Era of Novel Agents: Results of the KMM2301 Study

在新型药物时代,复发/难治性多发性骨髓瘤患者的二次挽救性自体造血干细胞移植:KMM2301 研究结果

Jung, Jongheon; Lee, Ji Hyun; Kim, Sung-Hyun; Lee, Jae Hoon; Yoo, Kwai Han; Do, Young Rok; Shin, Ho-Jin; Kim, Kihyun; Yoon, Sang Eun; Yoon, Dok Hyun; Cho, Hyungwoo; Kang, Hye Jin; Byun, Ja Min; Jo, Jae-Cheol; Lee, Seung-Shin; Lee, Won Sik; Lee, Je-Jung; Jung, Sung-Hoon; Lee, Myung-Won; Yi, Jun Ho; Park, Ju-Hyun; Min, Chang-Ki; Eom, Hyeon-Seok

Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study

在不适合移植的多发性骨髓瘤患者中,VMP诱导治疗后硼替佐米维持治疗的真实世界疗效:一项目标试验模拟研究

Lee, Jung Yeon; Choi, Suein; Jung, Seungpil; Park, Sung-Soo; Kim, Jin Seok; Shin, Seung-Hwan; Jeon, Young-Woo; Yahng, Seung-Ah; Lee, Je-Jung; Kim, Hyo Jung; Lee, Gyeong-Won; Eom, Hyeon-Seok; Kim, Min Kyoung; Kim, Yundeok; Kwon, Jihyun; Min, Chang-Ki

Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

嵌合抗原受体T细胞疗法在实体瘤治疗中的挑战和局限性:为什么其获批仅限于血液系统恶性肿瘤?

Vo, Manh-Cuong; Tran, Van-Dinh-Huan; Nguyen, Van-Tan; Ruzimurodov, Nodirjon; Trung, Dung Tran; Kim, Sang Ki; Jung, Sung-Hoon; Lee, Je-Jung

An impermeable copper surface monolayer with high-temperature oxidation resistance

具有耐高温氧化性的不透水铜表面单层

Kim, Su Jae; Kim, Young-Hoon; Lamichhane, Bipin; Regmi, Binod; Lee, Yousil; Yang, Sang-Hyeok; Kim, Seon Je; Jung, Min-Hyoung; Jang, Jae Hyuck; Jeong, Hu Young; Chi, Miaofang; Seong, Maeng-Je; Choi, Hak Soo; Kim, Seong-Gon; Kim, Young-Min; Jeong, Se-Young

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)

泊马度胺环磷酰胺地塞米松与泊马度胺地塞米松单药治疗复发或难治性多发性骨髓瘤的随机3期研究:亚洲骨髓瘤网络研究(AMN003)

Kim, Jin Seok; Song, Yang; Jen, Wei-Ying; Chim, C S; Lee, Je-Jung; Yoon, Sung-Soo; Ng, Soo Chin; Gan, Gin Gin; Handa, Hiroshi; Lee, Jae Hoon; Kim, Kihyun; Ito, Shigeki; Huang, Jeffrey Shang-Yi; Min, Chang Ki; Ooi Gaik Ming, Melissa; de Mel, Sanjay; Soekojo, Cinnie; Li, Xinhua; Awasthi, Neha; Pokharkar, Yogesh; Durie, Brian Gm; Chng, Wee-Joo

Reduction of lymphotoxin beta receptor induces cellular senescence via the MDMX-p53 pathway.

淋巴毒素β受体的减少通过MDMX-p53通路诱导细胞衰老

Kim So Young, Lee Bin, Lee Je-Jung, Kwak Man Sup, Rhee Woo Joong, Park In Ho, Shin Jeon-Soo

Combination therapy with expanded natural killer cells and atezolizumab exerts potent antitumor immunity in small cell lung cancer

扩增自然杀伤细胞与阿特珠单抗联合疗法在小细胞肺癌中发挥强大的抗肿瘤免疫作用

Vo, Manh-Cuong; Nguyen, Van-Tan; Tran, Van-Dinh-Huan; Oh, Hyung-Joo; Jung, Sung-Hoon; Bae, Woo Kyun; Lee, Je-Jung; Oh, In-Jae

Clinical Implication of Sequential Circulating Tumor DNA Assessments for the Treatment of Diffuse Large B-Cell Lymphoma

连续循环肿瘤DNA检测在弥漫性大B细胞淋巴瘤治疗中的临床意义

Song, Ga-Young; Park, Joo Heon; Kang, Sae-Ryung; Han, Seung Jung; Jung, Youjin; Son, Minuk; Jang, Ho Cheol; Kim, Mihee; Ahn, Seo-Yeon; Jung, Sung-Hoon; Ahn, Jae-Sook; Lee, Je-Jung; Kim, Hyeoung-Joon; Yang, Deok-Hwan